Extended Data Fig. 2: Associations between individual lysoPCs and AD and biomarkers.
From: Lysophosphatidylcholines are associated with amyloidosis in early stages of Alzheimer’s disease
The * indicates FDR q-value < 0.05 and the # indicates an FDR q-value for interaction with APOE ε4 carrier < 0.05. There was no significant interaction with APOE ε4 in the relationship between clinical AD or biomarker-supported AD and any of the individual lysoPCs (all adducts detected, adduct number indicated by a*).
